Literature DB >> 21160460

Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.

Gary S Hill1, Khalil El Karoui2, Alexandre Karras3, Chantal Mandet4, Jean-Paul Duong Van Huyen4, Dominique Nochy4, Patrick Bruneval4.   

Abstract

IgA nephropathy (IgAN) often shows lesions morphologically identical with those of focal segmental glomerulosclerosis (FSGS). In order to determine the possible role of FSGS in IgAN lesions, we measured glomerular capsular adhesions, often the first step toward FSGS, in biopsies from 127 patients with IgAN, 100 with lupus nephritis, and 26 with primary FSGS. Capsular adhesions with no lesions in the underlying tuft, consistent with podocyte abnormality or loss, were found regularly in FSGS and IgAN, but infrequently in lupus. Fifteen biopsies of patients with IgAN were studied immunohistochemically using markers for podocytes, Bowman's parietal epithelial cells, proliferating cells, and macrophages. Cytokeratins CK-8 and C2562 differentiated normal podocytes (negative) from parietal epithelial cells (variably positive). There was focal loss of the podocyte markers synaptopodin, glomerular epithelial protein 1 (GLEPP-1), nephrin, and vascular endothelial growth factor (VEGF), particularly at sites of capsular adhesions in otherwise histologically normal glomeruli. Cells displaying the parietal epithelial cell markers PAX2 (paired box gene 2) and the cytokeratins were also positive for the proliferating cell marker, proliferating cell nuclear antigen. These cells gathered at sites of adhesion, and in response to active lesions in the tuft, grew inward along the adhesion onto the tuft, forming a monolayer positive for parietal markers and the podocyte marker Wilms tumor protein-1 (WT-1). These cells deposited a layer of collagen over the sclerosing tuft. Thus, all biopsies of patients with IgAN had changes basically identical to those classically described in FSGS. Hence, our study strongly suggests that podocytopathy of a type similar to that in primary FSGS occurs frequently in IgAN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160460     DOI: 10.1038/ki.2010.466

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.

Authors:  Christoph Kuppe; Hermann-Josef Gröne; Tammo Ostendorf; Toin H van Kuppevelt; Peter Boor; Jürgen Floege; Bart Smeets; Marcus J Moeller
Journal:  Kidney Int       Date:  2015-04-08       Impact factor: 10.612

2.  Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis.

Authors:  Jingyuan Xie; Xu Hao; Evren U Azeloglu; Hong Ren; Zhaohui Wang; Jun Ma; Jian Liu; Xiaodan Ma; Weiming Wang; Xiaoxia Pan; Wen Zhang; Fang Zhong; Yifu Li; Guoyu Meng; Krzysztof Kiryluk; John Cijiang He; Ali G Gharavi; Nan Chen
Journal:  Kidney Int       Date:  2015-06-03       Impact factor: 10.612

3.  A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy.

Authors:  Khalil El Karoui; Gary S Hill; Alexandre Karras; Christian Jacquot; Luc Moulonguet; Olivier Kourilsky; Véronique Frémeaux-Bacchi; Michel Delahousse; Jean-Paul Duong Van Huyen; Alexandre Loupy; Patrick Bruneval; Dominique Nochy
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

4.  Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.

Authors:  Rin Asao; Katsuhiko Asanuma; Fumiko Kodama; Miyuki Akiba-Takagi; Yoshiko Nagai-Hosoe; Takuto Seki; Yukihiko Takeda; Isao Ohsawa; Satoshi Mano; Kiyoshi Matsuoka; Hiroyuki Kurosawa; Shinya Ogasawara; Yoshiaki Hirayama; Sakari Sekine; Satoshi Horikoshi; Masanori Hara; Yasuhiko Tomino
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

5.  Mutations in INF2 may be associated with renal histology other than focal segmental glomerulosclerosis.

Authors:  Anja K Büscher; Nora Celebi; Peter F Hoyer; Hanns-Georg Klein; Stefanie Weber; Julia Hoefele
Journal:  Pediatr Nephrol       Date:  2017-10-06       Impact factor: 3.714

6.  Renal cell markers: lighthouses for managing renal diseases.

Authors:  Shivangi Agarwal; Yashwanth R Sudhini; Onur K Polat; Jochen Reiser; Mehmet M Altintas
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-11

7.  The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.

Authors:  Hideo Tsushima; Ken-Ichi Samejima; Masahiro Eriguchi; Takayuki Uemura; Hikari Tasaki; Fumihiro Fukata; Masatoshi Nishimoto; Takaaki Kosugi; Kaori Tanabe; Keisuke Okamoto; Masaru Matsui; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2022-04-15       Impact factor: 2.617

8.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

9.  Oxford-MEST classification in IgA nephropathy patients: A report from Iran.

Authors:  Hamid Nasri; Mojgan Mortazavi; Ali Ghorbani; Heshmatollah Shahbazian; Soleiman Kheiri; Azar Baradaran; Afsoon Emami-Naieni; Maryam Saffari; Saeed Mardani; Ali Momeni; Yahya Madihi; Milad Baradaran-Ghahfarokhi; Mahmoud Rafieian-Kopaie; Parin Hedayati; Shahzad Baradaran; Mohammadreza Ardalan; Shahram Sajjadieh; Naziheh Assarzadegan; Seyed Mohammad Ahmadi Soleimani; Mohamad Reza Tamadon
Journal:  J Nephropathol       Date:  2012-04-05

10.  Understanding the mechanisms of proteinuria: therapeutic implications.

Authors:  Jorge E Toblli; P Bevione; F Di Gennaro; L Madalena; G Cao; M Angerosa
Journal:  Int J Nephrol       Date:  2012-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.